Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

News Daily News

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

July 09, 2025

June 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

June 26, 2025

Greater Frailty Means More Complications, Higher Mortality After PCI

News Daily News

Greater Frailty Means More Complications, Higher Mortality After PCI

June 16, 2025

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

News Daily News

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

June 13, 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

May 30, 2025

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

April 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

April 18, 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

News Conference News ACC 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

Michael O'Riordan

April 08, 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

News Conference News ACC 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

April 02, 2025

March 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

March 21, 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

February 14, 2025

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

February 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

February 01, 2025

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.